{"id":90,"date":"2025-04-15T09:59:47","date_gmt":"2025-04-15T08:59:47","guid":{"rendered":"http:\/\/efanet.org\/annual-report\/?page_id=90"},"modified":"2025-05-16T15:39:52","modified_gmt":"2025-05-16T14:39:52","slug":"efa-prevent-policy","status":"publish","type":"page","link":"https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/","title":{"rendered":"EFA Prevent Policy"},"content":{"rendered":"\n

Food labelling and allergy management<\/h2>\n\n\n\n

In 2024, EFA\u2019s work to ensure that consumers with food allergy can make safe and informed food choices was highly productive.<\/p>\n\n\n\n

We significantly boosted our advocacy towards the Codex Alimentarius Commission in a year that was a critical for setting the international rules for the labelling of allergens in food. Through our Observer membership at Codex, we informed several e-working groups: the one reviewing the General Standard for the Labelling of Prepacked Food (GSLPF), the one developing the first ever international guidelines for e-commerce of food products and the one looking at the use of technology for food labelling. EFA addressed to Codex a public statement[1]<\/a> with the position of our food allergy community for the effective use of Precautionary Allergen Labelling. Finally, EFA\u2019s President Marcia Podest\u00e0 and Sabine Schnadt from DAAB, our German member organisation attended the 48th<\/sup> Codex Committee for Food Labelling (CCFL) meeting in Canada, bringing the voice of food allergy patients to the highest international standards-setting level.<\/p>\n\n\n\n

\"\"
EFA President Marcia Podest\u00e0 and Sabine Schnadt from DAAB at the CCFL meeting in Canada. <\/figcaption><\/figure>\n\n\n\n

EFA kept its focus tight at the EU level too, discussing with key food policy-makers and through our participation in the annual EFSA Stakeholder Forum meeting, which focused on innovation in food safety. All the while, EFA also brought the European voice of food allergy patients to international fora such as the at GA2LEN Anaphylaxis and Food Allergy Forum (GA2FA)[2]<\/a> with medical professionals and at the Confectionary Industry Meeting (CAOBISCO)[3]<\/a>.<\/p>\n\n\n\n

Finally, EFA collaborated with the Global Allergy and Asthma European Network (GA2LEN) for the publication of two joint papers[4]<\/a>[5]<\/a> on the management and response to food anaphylaxis and the management of food allergy and serious allergic reactions (anaphylaxis) at school.<\/p>\n\n\n\n

\n
\"\"<\/a><\/figure>\n\n\n\n
\"\"<\/a><\/figure>\n
On the left, EFA President Marcia Podest\u00e0 at the GA2FA Conference in Padua.
On the right, EFA Senior Policy Advisor Panagiotis Chaslaridis at the CAOBISCO Congress in Brussels.<\/figcaption><\/figure>\n\n\n\n

EFA\u2019s community engagement was informed and steered by our genuine and dedicated food allergy patient community who gathers at the EFA Food Allergy Working Group. We are deeply grateful to each one of them.<\/p>\n\n\n\n

6<\/div>
Food Allergy Working Group meetings, 1 ad hoc<\/div><\/div>
10<\/div>
submissions to Codex consultations<\/div><\/div>
2<\/div>
high-level conferences as speakers (GA2FA, CAOBISCO)<\/div><\/div>
1<\/div>
meeting with European Commission DG SANTE to discuss upcoming Codex negotiations affecting food allergy patients in Europe<\/div><\/div>
1<\/div>
public statement on PAL<\/div><\/div>
3<\/div>
key publications (2 GA2LEN\/EFA papers, EFA PAL statement)<\/div><\/div><\/div><\/div>\n\n\n\n
EFA delegates\u2019 overview of the key CCFL48 discussions in Canada<\/div><\/div><\/div>
As a community, we have achieved a lot in our effort to ensure safe, clear allergen labelling for all. But equally important are the challenges that lie ahead<\/blockquote><\/div>\n\n\n\n

Tobacco control<\/h2>\n\n\n\n

2024 marked a difficult turning point to achieve the EU\u2019s goal of the \u2018tobacco-free generation\u2019 in Europe. With a legislative tobacco control agenda already delayed, the new European Parliament elected in 2024 broke the previous consensus in fighting tobacco smoke and tried to water down the European Commission proposal for smokefree environments. EFA co-signed a statement calling on the Ministers of Health at the Council to support the science-based proposal by the European Commission towards protecting vulnerable groups from harmful second-hand smoke[5]<\/a>.<\/p>\n\n\n\n

Together with our partners in the European Lung Health Group (ELHG), EFA welcomed the long-awaited adoption of the updated Council recommendation on Smoke- and Aerosol Free Environments[6]<\/a>. The recommendation brings robust directions for Member States to advance towards clean air from smoke in public spaces. It extends the protection scope to more outdoors public areas in the EU and it recommends restricting smoke and aerosols of new smoking products, such as electronic cigarettes and heated tobacco products. Our Youth Parliament member wrote a blog post<\/a> on the issue, bearing the perspective of young respiratory patients and sharing thoughts on the smoke-free policies that Spain proposed in 2024. <\/p>\n\n\n

\n
\"\"<\/figure>\n<\/div>\n\n\n
1<\/div>
joint statement with the ELHG<\/div><\/div>
1<\/div>
joint statement with 16 other organisations representing patients and doctors across different diseases areas<\/div><\/div>
1<\/div>
Youth Parliament blog post<\/div><\/div><\/div><\/div>\n\n\n\n

Exposure to chemicals<\/h2>\n\n\n\n
\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n
Partnership for the Assessment of Rick of Chemicals (PARC)<\/em> Conference<\/em><\/figcaption><\/figure>\n\n\n\n

EFA continued to bring the voice of allergy, atopic dermatitis, asthma and COPD patients to key initiatives aimed at reducing harmful atopic and respiratory exposure to chemicals.<\/p>\n\n\n\n

EFA\u2019s Director Susanna Palkonen joined the high-level \u2018Shaping Tomorrow conference\u2019 organised by the European Chemicals Agency (ECHA), engaging with key policymakers and stakeholders and advocating for higher standards of chemicals safety in the EU[7]<\/a>. EFA remains the only patient organisation with the status of accredited stakeholder at ECHA.<\/p>\n\n\n\n

EFA also joined the 3rd Stakeholder Forum meeting<\/a> of the Partnership for the Assessment of Risk from Chemicals (PARC)<\/a>, an EU-funded project that aims to advance next-generation chemical risk assessment to protect human health and the environment. Represented by Artur Badyda from our member the Polish Federation of Asthma, Allergy and COPD Patients\u2019 Organisations, we urged to prioritise to occupational exposure and on the effects of long-term exposure to chemicals. Moreover, we asked ECHA to step up actions to address chemicals such as bisphenol, phthalates, and those contained in pesticides, which have been associated with skin allergies and asthma.<\/p>\n\n\n\n

1<\/div>
high-level conference of an EU regulatory agency (ECHA)<\/div><\/div>
1<\/div>
stakeholder meeting of an EU-funded project (PARC)<\/div><\/div><\/div><\/div>\n\n\n\n

Indoor air quality<\/h2>\n\n\n\n

Contrasting with  the attention that is given to developing and enforcing legislation to reduce air pollution outdoors, there is only incipient EU focus to air quality indoors. Facing such a limited landscape, EFA worked tirelessly throughout 2024 to position Indoor Air Quality as a priority in Europe.<\/p>\n\n\n\n

EFA held meetings with the national authorities of Belgium[9]<\/a> and Germany working on indoor air quality. We discussed patients\u2019 concerns as they are both assessing how to implement more protective measures more effectively. In addition, EFA participated in the High-level Construction Forum, a European Commission policy webinar addressing indoor air quality specifically from the perspective of construction products.<\/p>\n\n\n\n

\"\"
From left to right: Karen Vande Casteele (AAK), Erika Colen (AAK), Lula Timmermans (FPS Public Health), Isabel Proa\u00f1o (EFA), Loucine Mekhitarian (FPS Public Health), Panagiotis Chaslaridis (EFA). <\/figcaption><\/figure>\n\n\n\n

We also brought the patients\u2019 voice to an event organised by the European Ventilation Industry Association (EVIA), where we discussed the public health dimension of indoor air pollution, including the role of indoor pollutants such as allergens, dampness, and emissions from consumer products[10]<\/a>. <\/p>\n\n\n

\n
\"\"
EFA Senior Policy Advisor Panagiotis Chaslaridis spoke at EVIA event in Brussels. <\/figcaption><\/figure>\n<\/div>\n\n\n

Beyond the active participation in events, EFA and its members co-shaped a response to the Guidelines on Indoor Air Quality and Asthma, initiated by the European Academy of Allergy and Clinical Immunology (EAACI). We welcomed the Guidelines\u2019 potential to enhance knowledge on the asthma triggers, but also called for a number of steps to support patients managing indoor air pollution: integrating indoor exposure assessments into individual asthma management plans; considering pollutants such as dust mites and tobacco smoke; and proper evaluation of ventilation systems.<\/p>\n\n\n\n

3<\/div>
members provided input to the EFA response to the EAACI IAQ & asthma guidelines<\/div><\/div>
2<\/div>
meetings national authorities\/agencies working on IAQ<\/div><\/div>
1<\/div>
external policy event as speaker<\/div><\/div><\/div><\/div>\n\n\n\n

Acknowledgements<\/h3>\n\n\n\n

We are grateful to our Belgian member Astma en Allergiekoepel for their participation in the meeting with the IAQ agency of the Belgian Ministry of Health; and our members Longfonds from the Netherlands, Allergy UK and the Swedish Asthma and Allergy Association for their invaluable input in our response to the EAACI Guidelines on IAQ & asthma.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Food labelling and allergy management In 2024, EFA\u2019s work to ensure that consumers with food allergy can make safe and informed food choices was highly productive. We significantly boosted our advocacy towards the Codex Alimentarius Commission in a year that was a critical for setting the international rules for the labelling of allergens in food. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":15,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page_2024.php","meta":{"_acf_changed":false,"inline_featured_image":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"class_list":["post-90","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nEFA Prevent Policy - EFA - Annual Report<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EFA Prevent Policy - EFA - Annual Report\" \/>\n<meta property=\"og:description\" content=\"Food labelling and allergy management In 2024, EFA\u2019s work to ensure that consumers with food allergy can make safe and informed food choices was highly productive. We significantly boosted our advocacy towards the Codex Alimentarius Commission in a year that was a critical for setting the international rules for the labelling of allergens in food. […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/\" \/>\n<meta property=\"og:site_name\" content=\"EFA - Annual Report\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/EFAPatients\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-16T14:39:52+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2025\/04\/Marcia-and-Sabine-in-Canada.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@EFA_Patients\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2024\\\/prevent\\\/efa-prevent-policy\\\/\",\"url\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2024\\\/prevent\\\/efa-prevent-policy\\\/\",\"name\":\"EFA Prevent Policy - EFA - Annual Report\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2024\\\/prevent\\\/efa-prevent-policy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2024\\\/prevent\\\/efa-prevent-policy\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Marcia-and-Sabine-in-Canada.jpg\",\"datePublished\":\"2025-04-15T08:59:47+00:00\",\"dateModified\":\"2025-05-16T14:39:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2024\\\/prevent\\\/efa-prevent-policy\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2024\\\/prevent\\\/efa-prevent-policy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2024\\\/prevent\\\/efa-prevent-policy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Marcia-and-Sabine-in-Canada.jpg\",\"contentUrl\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Marcia-and-Sabine-in-Canada.jpg\",\"width\":1600,\"height\":662},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2024\\\/prevent\\\/efa-prevent-policy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Annual Report 2024\",\"item\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Prevent\",\"item\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2024\\\/prevent\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"EFA Prevent Policy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#website\",\"url\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/\",\"name\":\"EFA - Annual Report\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#organization\",\"name\":\"EFA\",\"url\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/EFA_logo_OFFICIAL.webp\",\"contentUrl\":\"http:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/EFA_logo_OFFICIAL.webp\",\"width\":1341,\"height\":742,\"caption\":\"EFA\"},\"image\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/EFAPatients\",\"https:\\\/\\\/x.com\\\/EFA_Patients\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/efanet\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EFA Prevent Policy - EFA - Annual Report","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/","og_locale":"en_GB","og_type":"article","og_title":"EFA Prevent Policy - EFA - Annual Report","og_description":"Food labelling and allergy management In 2024, EFA\u2019s work to ensure that consumers with food allergy can make safe and informed food choices was highly productive. We significantly boosted our advocacy towards the Codex Alimentarius Commission in a year that was a critical for setting the international rules for the labelling of allergens in food. […]","og_url":"https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/","og_site_name":"EFA - Annual Report","article_publisher":"https:\/\/www.facebook.com\/EFAPatients","article_modified_time":"2025-05-16T14:39:52+00:00","og_image":[{"url":"http:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2025\/04\/Marcia-and-Sabine-in-Canada.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@EFA_Patients","twitter_misc":{"Estimated reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/","url":"https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/","name":"EFA Prevent Policy - EFA - Annual Report","isPartOf":{"@id":"https:\/\/efanet.org\/annual-report\/#website"},"primaryImageOfPage":{"@id":"https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/#primaryimage"},"image":{"@id":"https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/#primaryimage"},"thumbnailUrl":"http:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2025\/04\/Marcia-and-Sabine-in-Canada.jpg","datePublished":"2025-04-15T08:59:47+00:00","dateModified":"2025-05-16T14:39:52+00:00","breadcrumb":{"@id":"https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/#primaryimage","url":"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2025\/04\/Marcia-and-Sabine-in-Canada.jpg","contentUrl":"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2025\/04\/Marcia-and-Sabine-in-Canada.jpg","width":1600,"height":662},{"@type":"BreadcrumbList","@id":"https:\/\/efanet.org\/annual-report\/2024\/prevent\/efa-prevent-policy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/efanet.org\/annual-report\/"},{"@type":"ListItem","position":2,"name":"Annual Report 2024","item":"https:\/\/efanet.org\/annual-report\/"},{"@type":"ListItem","position":3,"name":"Prevent","item":"https:\/\/efanet.org\/annual-report\/2024\/prevent\/"},{"@type":"ListItem","position":4,"name":"EFA Prevent Policy"}]},{"@type":"WebSite","@id":"https:\/\/efanet.org\/annual-report\/#website","url":"https:\/\/efanet.org\/annual-report\/","name":"EFA - Annual Report","description":"","publisher":{"@id":"https:\/\/efanet.org\/annual-report\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/efanet.org\/annual-report\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/efanet.org\/annual-report\/#organization","name":"EFA","url":"https:\/\/efanet.org\/annual-report\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/efanet.org\/annual-report\/#\/schema\/logo\/image\/","url":"http:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2025\/05\/EFA_logo_OFFICIAL.webp","contentUrl":"http:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2025\/05\/EFA_logo_OFFICIAL.webp","width":1341,"height":742,"caption":"EFA"},"image":{"@id":"https:\/\/efanet.org\/annual-report\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/EFAPatients","https:\/\/x.com\/EFA_Patients","https:\/\/www.linkedin.com\/company\/efanet\/"]}]}},"coauthors":[],"author_meta":{"author_link":"https:\/\/efanet.org\/annual-report\/author\/quentin\/","display_name":"quentin"},"relative_dates":{"created":"Posted 12 months ago","modified":"Updated 11 months ago"},"absolute_dates":{"created":"Posted on 15 April 2025","modified":"Updated on 16 May 2025"},"absolute_dates_time":{"created":"Posted on 15 April 2025 09:59","modified":"Updated on 16 May 2025 15:39"},"featured_img_caption":"","featured_img":false,"series_order":"","_links":{"self":[{"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages\/90","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/comments?post=90"}],"version-history":[{"count":19,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages\/90\/revisions"}],"predecessor-version":[{"id":394,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages\/90\/revisions\/394"}],"up":[{"embeddable":true,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages\/15"}],"wp:attachment":[{"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/media?parent=90"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}